WealthSource Partners’s Bristol-Myers Squibb BMY Stock Holding History

WealthSource Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$997K	Sell	19,428 -2,161	-10%	-$113K	0.06%	200
2023 Q3	$1.25M	Sell	21,589 -2,572	-11%	-$158K	0.09%	165
2023 Q2	$1.55M	Sell	24,161 -1,518	-6%	-$102K	0.1%	151
2023 Q1	$1.78M	Sell	25,679 -3,641	-12%	-$257K	0.12%	137
2022 Q4	$2.11M	Sell	29,320 -4,698	-14%	-$354K	0.15%	112
2022 Q3	$2.42M	Sell	34,018 -4,886	-13%	-$354K	0.18%	94
2022 Q2	$3M	Sell	38,904 -36,311	-48%	-$2.77M	0.22%	77
2022 Q1	$5.49M	Buy	75,215 +49,587	+193%	+$3.33M	0.37%	49
2021 Q4	$1.6M	Buy	25,628 +2,063	+9%	+$121K	0.13%	129
2021 Q3	$1.39M	Sell	23,565 -745	-3%	-$49.1K	0.12%	134
2021 Q2	$1.62M	Sell	24,310 -1,114	-4%	-$72.6K	0.14%	112
2021 Q1	$1.6M	Buy	25,424 +935	+4%	+$58.2K	0.16%	99
2020 Q4	$1.52M	Sell	24,489 -4,983	-17%	-$306K	0.18%	76
2020 Q3	$1.78M	Buy	29,472 +4,726	+19%	+$284K	0.24%	54
2020 Q2	$1.46M	Buy	24,746 +5,540	+29%	+$331K	0.21%	60
2020 Q1	$1.07M	Buy	19,206 +1,467	+8%	+$89.7K	0.17%	84
2019 Q4	$1.14M	Buy	17,739 +10,562	+147%	+$605K	0.15%	124
2019 Q3	$364K	Sell	7,177 -4,003	-36%	-$188K	0.05%	292
2019 Q2	$507K	Buy	+11,180	New	+$521K	0.08%	235
2016 Q3	–	Sell	-2,727	Closed	-$201K	–	262
2016 Q2	$201K	Buy	+2,727	New	+$193K	0.08%	243

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

WealthSource Partners's BMY Position: Q4 2023 in Review

WealthSource Partners reduced its Bristol-Myers Squibb (BMY) stake by 10% in Q4 2023, selling an estimated $113K and leaving 19,428 shares worth $997K. The position accounts for 0.06% of the portfolio, ranked #200.

WealthSource Partners first reported a position in BMY in Q2 2016 and has held it in 20 quarters since. The position peaked at $5.49M in Q1 2022. 2,364 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

WealthSource Partners held 19,428 shares of Bristol-Myers Squibb worth $997K as of Q4 2023.
WealthSource Partners sold 2,161 Bristol-Myers Squibb shares in Q4 2023, an estimated $113K.
Bristol-Myers Squibb made up 0.06% of WealthSource Partners's portfolio in Q4 2023, its #200 holding.
WealthSource Partners first reported a position in Bristol-Myers Squibb in Q2 2016 and has held it in 20 quarters since.
WealthSource Partners's Bristol-Myers Squibb position peaked at $5.49M in Q1 2022.
2,364 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on WealthSource Partners's 13F filing for Q4 2023, filed 16 Jan 2024.